Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes Amgen | Reuters.com
Drug-maker Teva fueled opioid addiction in NY, jury finds | Business Insurance
US Supreme Court sides with Teva in drug dispute
An employee of Teva Pharmaceutical Industries carries a box at the company's Jerusalem oral solid dosage plant (OSD) December 21, 2011. Israel-based Teva is the world's leading generic drugmaker. REUTERS/Ronen Zvulun (JERUSALEM -
Teva gets FDA approval for cancer drug | Reuters
Reuters: Teva to pay US government $519 million over foreign bribery charges - Dec. 22, 2016 | KyivPost
Teva Pharmaceutical Industries Ltd | Reuters
TEVA Stock Price and Chart — NYSE:TEVA — TradingView
Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
Teva, Amgen End Dispute Over Generic Cinacalcet HCl Tablets
West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: Reuters | Markets Insider
Walgreens, Teva accused of fueling opioid addiction in quest for new markets | Reuters
Teva charged in US price-fixing investigation | Financial Times
Teva CEO exits in ongoing crisis of confidence at drugmaker | Reuters
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Teva settles shareholder lawsuit over generic drug | Business Insurance
Oklahoma Reaches $85 Million Settlement With Teva Pharmaceuticals Ahead of Trial
TEVA stock lower as company eyes up to $3.6 billion to settle opioid claims - Reuters | Seeking Alpha
CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports | Ctech
Rhode Island takes Teva to trial in multibillion-dollar opioid case - The Jerusalem Post
Teva Pharmaceutical Industries Ltd
Teva Pharmaceuticals to Lay Off 14,000 People
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters
Teva's $15B free drug opioid settlement might be a great deal in the long run: analyst | Fierce Pharma
GSK's $235 million verdict revived against Teva, again | Reuters
